These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2446008)

  • 1. Role of the host immune response in selection of equine infectious anemia virus variants.
    Carpenter S; Evans LH; Sevoian M; Chesebro B
    J Virol; 1987 Dec; 61(12):3783-9. PubMed ID: 2446008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
    Salinovich O; Payne SL; Montelaro RC; Hussain KA; Issel CJ; Schnorr KL
    J Virol; 1986 Jan; 57(1):71-80. PubMed ID: 3001367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Brief report.
    Kono Y
    Arch Virol; 1988; 98(1-2):91-7. PubMed ID: 2829799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.
    O'Rourke KI; Perryman LE; McGuire TC
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of antigenic variation by the equine infectious anemia virus.
    McGuire TC; O'Rourke K; Cheevers WP
    Contrib Microbiol Immunol; 1987; 8():77-89. PubMed ID: 3040337
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus.
    Montelaro RC; Parekh B; Orrego A; Issel CJ
    J Biol Chem; 1984 Aug; 259(16):10539-44. PubMed ID: 6206055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
    Taylor SD; Leib SR; Carpenter S; Mealey RH
    J Virol; 2010 Jul; 84(13):6536-48. PubMed ID: 20392850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of EIAV immunogenicity during persistent infections: humoral responses and antigen targets.
    Montelaro RC; Ball JM; Issel CJ
    Dev Biol Stand; 1990; 72():19-30. PubMed ID: 1704323
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of equine infectious anemia virus escape from neutralizing antibody responses define epitope specificity.
    Sponseller BA; Clark SK; Friedrich RA
    Viral Immunol; 2012 Aug; 25(4):324-8. PubMed ID: 22746986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
    Zhang W; Lonning SM; McGuire TC
    J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody escape kinetics of equine infectious anemia virus infection of horses.
    Schwartz EJ; Nanda S; Mealey RH
    J Virol; 2015 Jul; 89(13):6945-51. PubMed ID: 25878104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine infectious anemia virus from infected horse serum.
    Nakajima H; Yoshino T; Ushimi C
    Infect Immun; 1974 Sep; 10(3):667-8. PubMed ID: 4372175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
    Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
    Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemagglutination-inhibition tests with different strains of equine infectious anemia virus.
    Sentsui H; Kono Y
    Am J Vet Res; 1981 Nov; 42(11):1949-52. PubMed ID: 6175255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.
    Ball JM; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 1992 Feb; 66(2):732-42. PubMed ID: 1370556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses in horses infected with equine infectious anemia virus adapted to tissue culture.
    Gutekunst DE; Becvar CS
    Am J Vet Res; 1979 Jul; 40(7):974-7. PubMed ID: 228570
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of equine infectious anemia virus in horse leukocyte cultures derived from horses in various stages of equine infectious anemia viral infection.
    Evans KS; Carpenter SL; Sevoian M
    Am J Vet Res; 1984 Jan; 45(1):20-5. PubMed ID: 6322623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes.
    Zhang W; Auyong DB; Oaks JL; McGuire TC
    Virology; 1999 Sep; 261(2):242-52. PubMed ID: 10497109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.